Pulmatrix, Inc. (PULM)
1.48
+0.06
(+4.23%)
USD |
NASDAQ |
Oct 23, 16:00
1.46
-0.02
(-1.35%)
After-Hours: 20:00
Pulmatrix Enterprise Value : 3.503M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.503M |
| October 22, 2026 | 3.284M |
| October 21, 2026 | 3.832M |
| October 20, 2026 | 3.321M |
| October 19, 2026 | 3.284M |
| October 16, 2026 | 3.065M |
| October 15, 2026 | 3.248M |
| October 14, 2026 | 3.102M |
| October 13, 2026 | 3.138M |
| October 12, 2026 | 3.321M |
| October 09, 2026 | 3.430M |
| October 08, 2026 | 3.675M |
| October 07, 2026 | 3.540M |
| October 06, 2026 | 3.321M |
| October 05, 2026 | 3.503M |
| October 02, 2026 | 3.832M |
| October 01, 2026 | 3.722M |
| September 30, 2026 | 3.650M |
| September 29, 2026 | 3.785M |
| September 28, 2026 | 3.905M |
| September 25, 2026 | 3.978M |
| September 24, 2026 | 4.197M |
| September 23, 2026 | 4.252M |
| September 22, 2026 | 4.307M |
| September 21, 2026 | 4.234M |
| Date | Value |
|---|---|
| September 18, 2026 | 3.357M |
| September 17, 2026 | 3.331M |
| September 16, 2026 | 3.211M |
| September 15, 2026 | 3.376M |
| September 14, 2026 | 3.394M |
| September 11, 2026 | 3.248M |
| September 10, 2026 | 3.430M |
| September 09, 2026 | 3.503M |
| September 08, 2026 | 3.193M |
| September 04, 2026 | 3.175M |
| September 03, 2026 | 3.065M |
| September 02, 2026 | 3.467M |
| September 01, 2026 | 3.668M |
| August 31, 2026 | 3.467M |
| August 28, 2026 | 3.613M |
| August 27, 2026 | 3.650M |
| August 26, 2026 | 3.668M |
| August 25, 2026 | 3.942M |
| August 24, 2026 | 3.759M |
| August 21, 2026 | 3.558M |
| August 20, 2026 | 3.576M |
| August 19, 2026 | 3.650M |
| August 18, 2026 | 3.759M |
| August 17, 2026 | 3.796M |
| August 14, 2026 | 3.722M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
| Johnson & Johnson | 662.44B |
| Eli Lilly & Co. | 1.245T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.036M |
| Total Expenses (Quarterly) | 1.036M |
| EPS Diluted (Quarterly) | -0.288 |
| Earnings Yield | -74.53% |
| Normalized Earnings Yield | -74.53 |